The risk-benefit ratio just isnt there. More broadly, she said, many of these compounds are designed for use later in life and not during adolescence, when the body is still actively developing
Effective transdermal delivery would require advanced technologies such as: Microneedle arrays : Tiny needles that create microscopic channels in the skin to facilitate drug absorption (these are minimally invasive devices rather than traditional patches) Chemical penetration enhancers : Substances that temporarily increase skin permeability Iontophoresis : Using electrical currents to drive charged molecules through the skin Nanoparticle formulations : Encapsulating drugs in carriers designed to cross skin barriers Several preclinical and early-stage studies have explored these approaches for GLP-1 delivery, with some promising results in laboratory and animal models
Gasbjerg LS, Helsted MM, Hartmann B, Jensen MH, Gabe MBN, Sparre-Ulrich AH, Veedfald S, Stensen S, Lanng AR, Bergmann NC, Christensen MB, Vilsbll T, Holst JJ, Rosenkilde MM, Knop FK
You're not alone, and you're right on schedule for what researchers call "Quitter's Day" - the second Friday in January, when most New Year's resolutions go to die
The formula is patented and protected (US Patent #11,160,750)
Salvo F, Moore N, Arnaud M, Robinson P, Raschi E, De Ponti F, et al